During the No Pay Copay promotion, members* with prescription drug coverage can save money by choosing covered generic drugs. You pay nothing!
- From January 1, 2007 to December 31, 2007, AmeriHealth Delaware and Pennsylvania will waive copayments/coinsurance on covered generic drugs.
- From January 1, 2007 to June 30, 2007, AmeriHealth New Jersey will waive copayments/coinsurance on covered generic drugs.
How the Promotion Works
- Have your prescriptions filled as you normally would at a participating FutureScripts® retail pharmacy or through the mail order service. Make sure you request the generic form of the drug.
- Your copayment or coinsurance amount will be waived for all covered generic prescriptions processed during the promotion. If your prescription drug plan has a deductible, you are required to meet the deductible and then you are eligible for the waiver.
This is a voluntary promotion designed to make prescription drugs more affordable for you. We encourage you to talk with your physician or pharmacist to see if switching to a generic drug might be right for you. For additional details on the No Pay Copay promotion, we invite you to read the Q&A.
Generic Drugs are Safe and Effective
Generic drugs offer you a money-saving alternative while providing the same quality, strength, and effectiveness as a brand drug.
According to the U.S. Food and Drug Administration (FDA), generic drugs are identical to their brand name drug equivalents in active ingredients, dosage, safety, strength, and performance. The only noticeable difference in generics and their brand name drug counterparts may be the shape and/or color of the drug.
There are also therapeutic generic alternatives, which are not the exact chemical equivalents of the brand name drugs, but treat the same medical conditions in the same ways as brand name drugs. These are also included in our No Pay Copay promotion. Learn more about the value of generic drugs.
Questions?
If you have questions about the No Pay Copay promotion, please contact Member Services.